CD8A and neoplasm: Additionally, studies have reported PD-1 expression increases on T cells and PD-L1 on tumor cells after RT, causing inactivation and depletion of CD8+ T cells, inhibiting the antitumor immune response and developing radiotherapy tolerance (46, 47).